Mucosal-associated invariant T (MAIT) cells mediate protective host responses in sepsis
- PMID: 33164745
- PMCID: PMC7679140
- DOI: 10.7554/eLife.55615
Mucosal-associated invariant T (MAIT) cells mediate protective host responses in sepsis
Abstract
Sepsis is a systemic inflammatory response to infection and a leading cause of death. Mucosal-associated invariant T (MAIT) cells are innate-like T cells enriched in mucosal tissues that recognize bacterial ligands. We investigated MAIT cells during clinical and experimental sepsis, and their contribution to host responses. In experimental sepsis, MAIT-deficient mice had significantly increased mortality and bacterial load, and reduced tissue-specific cytokine responses. MAIT cells of WT mice expressed lower levels of IFN-γ and IL-17a during sepsis compared to sham surgery, changes not seen in non-MAIT T cells. MAIT cells of patients at sepsis presentation were significantly reduced in frequency compared to healthy donors, and were more activated, with decreased IFN-γ production, compared to both healthy donors and paired 90-day samples. Our data suggest that MAIT cells are highly activated and become dysfunctional during clinical sepsis, and contribute to tissue-specific cytokine responses that are protective against mortality during experimental sepsis.
Keywords: MAIT cells; human; immunology; inflammation; innate-like T cell; medicine; mouse; sepsis.
© 2020, Trivedi et al.
Conflict of interest statement
ST, DL, CA, CA, AB, EM, OJ, AT, MM, RC, JH, MR, DL No competing interests declared
Figures
References
-
- American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions for Sepsis and organ failure and guidelines for the use of innovative therapies in Sepsis. Critical Care Medicine. 1992;20:864–874. - PubMed
-
- Andreu-Ballester JC, Tormo-Calandín C, Garcia-Ballesteros C, Pérez-Griera J, Amigó V, Almela-Quilis A, Ruiz del Castillo J, Peñarroja-Otero C, Ballester F. Association of γδ T cells with disease severity and mortality in septic patients. Clinical and Vaccine Immunology. 2013;20:738–746. doi: 10.1128/CVI.00752-12. - DOI - PMC - PubMed
-
- Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for Sepsis and organ failure and guidelines for the use of innovative therapies in Sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/Society of critical care medicine. Chest. 1992;101:1644–1655. doi: 10.1378/chest.101.6.1644. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
